A prospective comparison of molecular assay and touch imprint cytology for intraoperative evaluation of sentinel lymph nodes

Chinese Medical Journal

Volumn 124, Issue 4, 2011, Pages 491-497

  Chen, Jia Jian ^a,b   Yang, Ben Long ^a,b   Chen, Jia Ying ^a,b   Zhang, Jia Xin ^a,b   Li, Da Li ^a,b   Xu, Wei Ping ^a,b   Xiao Li, Xu ^a,b   Yang, Wen Tao ^a,b   Shao, Zhi Min ^a,b   Shen, Zhen Zhou ^a,b   Wang, Yong Sheng ^c   Wu, Jiong ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Breast carcinoma; Intraoperative diagnosis; Sentinel node biopsy; Touch imprint cytology

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST LYMPH NODE ASSAY; BREAST SURGERY; CANCER SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE PERIOD; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; TOUCH IMPRINT CYTOLOGY;

ADULT; AGED; CYTODIAGNOSIS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY;

EID: 79951808625     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.04.002     Document Type: Article

References (29)

1. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-1822.
2. Copeland EM III. Is axillary dissection necessary for T1 carcinoma of the breast? J Am Coll Surg 1997; 184: 397-398.
3. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-399.
4. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553.
5. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standeard axillary treastment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98: 599-609.
6. Creager AJ, Geisinger KR, Shiver SA, Perrier ND, Shen P, Ann Shaw J, et al. Intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma by imprint cytology. Mod Pathol 2002; 15: 1140-1147.
7. Liang R, Craik J, Juhasz ES, Harman CR. Imprint cytology versus frozen section: intraoperative analysis of sentinel lymph nodes in breast cancer. ANZ J Surg 2003; 73: 597-599.
8. Aihara T, Munakata S, Morino H, Takatsuka Y. Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann Surg Oncol 2004; 11: 747-750.
9. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S, et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 2000; 87: 597-601.
10. Creager AJ, Geisinger KR, Perrier ND, Shen P, Shaw JA, Young PR, et al. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg 2004; 239: 61-66.
11. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 966-978.
12. Blumencranz P, Whitworth PW, Deck K, Rosenberg A, Reintgen D, Beitsch P, et al. Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 2007; 194: 426-432.
13. Julian TB, Blumencranz P, Deck K, Whitworth P, Berry DA, Berry SM, et al. Novel intra-operative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol 2008; 26: 3338-3345.
14. Backus J, Laughlin T, Wang Y, Belly R, White R, Baden J, et al. Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn 2005; 7: 327-336.
15. Chen JJ, Huang XY, Liu ZB, Chen TW, Cheng JY, Yang WT, et al. Sentinel node biopsy and quality of life measures in a Chinese population. Eur J Surg Oncol 2009; 35: 921-927.
16. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 7703-7720.
17. Mansel RE, Goyal A, Douglas-Jones A, Woods V, Goyal S, Monypenny I, et al. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study. Breast Cancer Res Treat 2009; 115: 595-600.
18. Veys I, Durbecq V, Majjaj S, Schobbens JC, Noterman D, Sirtaine N, et al. Eighteen months clinical experience with the GeneSearch breast lymph node assay. Am J Surg 2009; 198: 203-209.
19. Tew K, Irwig L, Matthews A, Crowe P, Macaskill P. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 2005; 92: 1068-1080.
20. Viale G, Dell'Orto P, Biasi MO, Stufano V, De Brito Lima LN, Paganelli G, et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcriptionpolymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg 2008; 247: 136-142.
21. Tjalma WA, Senten LL. The management of ectopic breast cancer-case report. Eur J Gynaecol Oncol 2006; 27: 414-416.
22. Maiorano E, Mazzarol GM, Pruneri G, Mastropasqua MG, Zurrida S, Orvieto E, et al. Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 2003; 27: 513-518.
23. Markopoulos C, Kouskos E, Kontzoglou K, Gogas G, Kyriakou V, Gogas J. Breast cancer in ectopic breast tissue. Eur J Gynaecol Oncol 2001; 22: 157-159.
24. Zynger DL, McCallum JC, Everton MJ, Yeldandi AV, Susnik B. Paracortical axillary sentinel lymph node ectopic breast tissue. Pathol Res Pract 2009; 205: 427-432.
25. Norton LE, Komenaka IK, Emerson RE, Murphy C, Badve S. Benign glandular inclusions a rare cause of a false positive sentinel node. J Surg Oncol 2007; 95: 593-596.
26. Migliorini L. Proliferative intraductal lesion arising in ectopic breast tissue within axillary lymph node. Histopathology 2006; 48: 316-317.
27. Carter BA, Jensen RA, Simpson JF, Page DL. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 2000; 113: 259-265.
28. Diaz NM, Vrcel V, Centeno BA, Muro-Cacho C. Modes of benign mechanical transport of breast epithelial cells to axillary lymph nodes. Adv Anat Pathol 2005; 12: 7-9.
29. Moore KH, Thaler HT, Tan LK, Borgen PI, Cody HS 3rd. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer 2004; 100: 929-934.